SPLICING ALTERATIONS IN LOW RISK MYELODYSPLASTIC SYNDROME, TGF-B PATHWAY DEREGULATION IN SF3B1 MUTATED PATIENTS

被引：0
|
作者：
Hajrullaj, H. [1 ]
Onorato, A. [1 ]
Valenzuela, M. [1 ]
Cristiano, A. [1 ]
Silvestrini, G. [1 ]
Pieraccioli, M. [2 ]
Galossi, E. [1 ]
Falconi, G. [1 ]
Hutter, S. [3 ]
Nadarajah, N. [3 ]
Latagliata, R. [4 ,5 ]
Haferlach, T. [3 ]
Bielli, P. [1 ]
Voso, M. T. [1 ]
Fabiani, E. [1 ,6 ]
机构：
[1] Univ Tor Vergata, Dept Biomed & Prevent, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Milan, Italy
[3] MLL Munich Leukemia Lab, Munich, Germany
[4] Sapienza Univ, Unita Operat Complessa UOC Ematol, Osped Belcolle, Rome, Italy
[5] Sapienza Univ, Div Cellular Biotechnol & Hematol, Rome, Italy
[6] UniCamillus St Camillus Int Univ Hlth Sci, Rome, Italy
来源：
HAEMATOLOGICA | 2024年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C20
引用
收藏
页码：23 / 24
页数：2
相关论文
共 50 条
  • [41] SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients With Lower-Risk Myelodysplastic Syndrome
    Falantes, Jose F.
    Marquez-Malaver, Francisco J.
    Carrillo, Estrella
    Garcia Culebras, Marta
    Morales, Rosario
    Prats, Concepcion
    Vargas, Maria T.
    Caballero, Teresa
    Rodriguez-Arboli, Eduardo
    Espigado, Ildefonso
    Perez-Simon, Jose Antonio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (12): : E1059 - E1066
  • [42] SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients with Lower-Risk Myelodysplastic Syndrome
    Falantes, Jose F.
    Marquez-Malaver, Francisco J.
    Carrillo-Cruz, Estrella
    Morales-Camacho, Rosario M.
    Prats-Martin, Concepcion
    Caballero, Teresa
    Rodriguez Arboli, Eduardo
    Espigado, Ildefonso
    Perez-Simon, Jose A.
    BLOOD, 2022, 140 : 6920 - 6922
  • [43] A CULTURE MODEL MIMICKING THE BM-NICHE ALLOWS FOR STUDYING THE DYSREGULATED ERYTHROPOIESIS OF SF3B1 MUTATED MYELODYSPLASTIC SYNDROME WITH RINGED SIDEROBLASTS
    Elvarsdottir, E. M.
    Mortera-Blanco, T.
    Dimitriou, M.
    Conte, S.
    Sander, B.
    Jansson, M.
    Douagi, I.
    Jacobsen, S. E.
    Hellstrom-Lindberg, E.
    HAEMATOLOGICA, 2016, 101 : 69 - 69
  • [44] Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts, thrombocytosis, and mutated JAK2/SF3B1 without anemia
    Neumann, Neil Montgomery
    Wen, Kwun Wah
    BLOOD, 2022, 139 (03) : 466 - 466
  • [45] Prognostic significance of SF3B1 mutations in patients with myelodysplastic syndromes: A meta-analysis
    Jafari, Pourya Arbab
    Sadeghian, Mohammad Hadi
    Miri, Hamid Heidarian
    Sadeghi, Ramin
    Bagheri, Ramin
    Lavasani, Sroush
    Souri, Saeid
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 145
  • [46] Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis with co-mutated JAK2 and SF3B1
    Reinig, Erica F.
    He, Rong
    BLOOD, 2017, 129 (05) : 656 - 656
  • [47] A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome
    Bondu, Sabrina
    Alary, Anne-Sophie
    Lefevre, Carine
    Houy, Alexandre
    Jung, Grace
    Lefebvre, Thibaud
    Rombaut, David
    Boussaid, Ismael
    Bousta, Abderrahmane
    Guillonneau, Francois
    Perrier, Prunelle
    Alsafadi, Samar
    Wassef, Michel
    Margueron, Raphael
    Rousseau, Alice
    Droin, Nathalie
    Cagnard, Nicolas
    Kaltenbach, Sophie
    Winter, Susann
    Kubasch, Anne-Sophie
    Bouscary, Didier
    Santini, Valeria
    Toma, Andrea
    Hunault, Mathilde
    Stamatoullas, Aspasia
    Gyan, Emmanuel
    Cluzeau, Thomas
    Platzbecker, Uwe
    Ades, Lionel
    Puy, Herve
    Stern, Marc-Henri
    Karim, Zoubida
    Yeux, Patrick Ma
    Nemeth, Zabeta
    Park, Sophie
    Ganz, Tomas
    Kautz, Leon
    Kosmiderl, Olivier
    Fontenay, Michaela
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (500)
  • [48] Erratum: Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells
    H Dolatshad
    A Pellagatti
    M Fernandez-Mercado
    B H Yip
    L Malcovati
    M Attwood
    B Przychodzen
    N Sahgal
    A A Kanapin
    H Lockstone
    L Scifo
    P Vandenberghe
    E Papaemmanuil
    C W J Smith
    P J Campbell
    S Ogawa
    J P Maciejewski
    M Cazzola
    K I Savage
    J Boultwood
    Leukemia, 2015, 29 : 1798 - 1798
  • [49] Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)-mutant myelodysplastic syndromes subtype
    Duetz, Carolien
    Westers, Theresia M.
    in 't Hout, Florentien E. M.
    Cremers, Eline M. P.
    Alhan, Canan
    Venniker-Punt, Bianca
    Visser-Wisselaar, Heleen A.
    Chitu, Dana A.
    de Graaf, Aniek O.
    Smit, Linda
    Jansen, Joop H.
    van de Loosdrecht, Arjan A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (04) : 798 - 803
  • [50] Increased sensitivity of SF3B1 mutated uveal melanoma by spliceosome inhibition
    Nguyen, Josephine
    Drabarek, Wojtek
    Leeflang, Aisha
    Brands, Tom
    van den Bosch, Thierry
    Verdijk, Robert
    van de Werken, Harmen
    van Riet, Job
    van der Horst, Niels
    Medico-Salsench, Eva
    Paridaens, Dion
    de Klein, Annelies
    Brosens, Erwin
    Kilic, Emine
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
12345